Cure Alzheimerās Fund presents: TAKING CONTROL OF ALZHEIMERāS THROUGH RESEARCH Thank you to all who attended our Symposium on Oct. 18 in Boston.Ā Below are questions and answers that were submitted that day. Presenters MODERATOR Robert Bazell, Chief Science & Health Correspondent, NBC News PANEL Rudolph Tanzi, Ph.D., Harvard Medical School/Massachusetts General Hospital; Chairman, CureAlz Research Consortium Robert Moir, ...
August 12, 2011
http://100Days100Courses.com āItās either a golferās dream or a golferās nightmare.ā Thatās the phrase one local golfer is using to describe his upcoming cross-country road trip that will see him play 100 golf courses in 100 days, a distance of 9,368 miles from the first course to the last, in hopes of raising ...
March 4, 2019
Cure Alzheimer’s Fund presented a webinar, Two Sides of Abeta for the Layperson, on Wednesday, Jan. 25, 2012. The presentation, moderated by David Shenk, author of the national bestseller The Forgetting, Alzheimer’s: Portrait of an Epidemic, featured Dr. Rudy Tanzi and Dr. Rob Moir. These Alzheimerās experts looked at Abeta and ...
January 25, 2012
Cure Alzheimer’s Fund’s Dr. Rudy Tanzi’s submitted answers to Senator Hillary Rodham Clintonās questions from the May 14, 2008, Senate Special Committee on Aging āThe Future of Alzheimerās: Breakthroughs and Challengesā Ā Questions How can we best identify those at risk for Alzheimer’s Disease? Are there effective new drugs coming out anytime soon? How critical ...
June 8, 2008
January 19, 2018
The Four Known Alzheimerās Genes Over the past several decades, it has become increasingly clear that inheritance plays a major role in Alzheimerās disease. The roughly 25,000 genes in the human genome are comprised of deoxyribonucleic acid (DNA) packaged into 24 different chromosomes, 1-22, X and Y. A geneās job is ...
April 18, 2011
Prepared by: Rudolph E. Tanzi, Ph.D. Chairperson, Cure Alzheimerās Fund Research Consortium Joseph P. and Rose F. Kennedy Professor of Neurology Harvard Medical School, Director, Genetics and Aging Research Unit, MassGeneral Institute for Neurodegenerative Disease Department of Neurology Massachusetts General Hospital 114 16th Street Charletown, MA [email protected] Timothy W. Armour President and CEO Cure Alzheimerās Fund 34 Washington Street Suite 300 Wellesly Hills, MA [email protected] The ...
August 20, 2009
Women develop Alzheimerās disease at twice the rate of men, and by the age of 75 a woman is three times more likely to have Alzheimerās than a man. Now a new website created by one of the nationās premier Alzheimerās research support organizations, Cure Alzheimerās Fund, is committed to ...
March 31, 2017
***** On January 31, 2024, in a press release, Biogen announced that it is discontinuing production of Aduhelm. From the release, “The company will discontinue the development and commercialization of ADUHELMĀ® (aducanumab-avwa) 100 mg/mL injection for intravenous use and will terminate the ENVISION clinical study.”Ā ***** Ā On April 7, 2022, the ...
May 3, 2022
At Cure Alzheimerās Fund, one of our successful strategies is to fund research that is innovative and based on high-quality science yet deemed risky by traditional funding sources. Our entrepreneurial approach and ability to provide funds in a quick and efficient manner allows us to fund potentially groundbreaking work that ...
December 15, 2010
